Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML

NCT05262465 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Adult Acute Myeloid Leukemia

Interventions

BIOLOGICAL: microtransplantation, HLA-mismatched donor peripheral stem cell infusion
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

guomei